DL-Carnitine → Tert-butyl acetyl carnitine chloride

HRID 35371

Reaktionsgleichung

Reaktionsgleichung von HRID 35371
[CH3:1][N+:2]([CH2:5][CH:6]([OH:11])[CH2:7][C:8]([O-:10])=[O:9])([CH3:4])[CH3:3].[C:12](CC([Cl:19])=O)([CH3:15])([CH3:14])[CH3:13].[CH3:20][CH2:21][O:22]CC>FC(F)(F)C(O)=O>[C:12]([CH:5]([N+:2]([CH3:3])([CH3:4])[CH3:1])[C:6]([C:21](=[O:22])[CH3:20])([CH2:7][C:8](=[O:10])[O-:9])[OH:11])([CH3:15])([CH3:14])[CH3:13].[Cl-:19]

Komponenten

5

Versuchsvorschrift

Carnitine chloride (1.97 g; 0.01 moles) was dissolved in trifluoroacetic acid (10 cc). To the solution tert-butyl acetyl chloride (1.4 cc; 0.01 moles) was slowly added under stirring. The resulting mixture was kept under stirring at room temperature for 48 hours. To the mixture Et2O was added and the thus obtained precipitate was filtered off. The raw product was crystallized from isopropanol-ethyl ether, thus obtaining a pure product. MP 164°-165° C. Yield 80%

Aufarbeitung

  1. stirringunder stirring at room temperature for 48 hours
  2. filtrationthe thus obtained precipitate was filtered off
  3. customThe raw product was crystallized from isopropanol-ethyl ether
  4. customthus obtaining a pure product

Quellen und Nachweise

ORD-Eintrag
ord-02fba49a08984876a7c07be75ff83bf6
Quelldatensatz
uspto-grants-1988_08
Patentnummer
US04766222

Verknüpfte Notizen

Wird geladen…